BioCentury
ARTICLE | Distillery Therapeutics

Endocrine / Metabolic

November 14, 2017 10:57 PM UTC

Mouse studies suggest the FBN1 preprotein cleavage product asprosin could help treat neonatal progeroid syndrome, which is caused by FBN1 mutations, and inhibiting asprosin could help treat obesity. I...

BCIQ Company Profiles

Baylor College of Medicine

BCIQ Target Profiles

Fibrillin 1 (FBN1)